Inventor
MARTIN JOEL H
US56 patents
⚠️ This page may combine multiple inventors who share the name “MARTIN JOEL H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
34 patentsUS8735095B2May 27, 2014
High affinity human antibodies to human IL-4 receptor
REGENERON PHARMA103 citations99
US8043617B2Oct 25, 2011
Human antibodies to human IL-6 receptor
REGENERON PHARMA91 citations99
US7608693B2Oct 27, 2009
High affinity human antibodies to human IL-4 receptor
REGENERON PHARMA158 citations99
US7582298B2Sep 1, 2009
High affinity antibodies to human IL-6 receptor
REGENERON PHARMA390 citations99
US9550837B2Jan 24, 2017
Therapeutic uses of anti-PCSK9 antibodies
REGENERON PHARMA31 citations98
US7879984B2Feb 1, 2011
Human antibodies to human CD20 and method of using thereof
REGENERON PHARMA116 citations98
US7605237B2Oct 20, 2009
High affinity human antibodies to human IL-4 receptor
REGENERON PHARMA194 citations98
US9353176B2May 31, 2016
Method of treating osteoarthritis with an antibody to NGF
REGENERON PHARMA67 citations97
US8357371B2Jan 22, 2013
Methods for treating hypercholesterolemia using antibodies to PCSK9
REGENERON PHARMA89 citations97
US7534868B1May 19, 2009
Human antibodies to human delta like ligand 4
REGENERON PHARMA38 citations96
US7488806B2Feb 10, 2009
Human antibodies to human delta like ligand 4
REGENERON PHARMA41 citations96
US7988967B2Aug 2, 2011
High affinity human antibodies to human nerve growth factor
REGENERON PHARMA39 citations95
US7794717B2Sep 14, 2010
High affinity human antibodies to human IL-4 receptor
REGENERON PHARMA34 citations95
US10023654B2Jul 17, 2018
Anti-PCSK9 antibodies
REGENERON PHARMA16 citations92
US9884916B2Feb 6, 2018
High affinity antibodies to human IL-6 receptor
REGENERON PHARMA13 citations92
US9475875B2Oct 25, 2016
Anti-EGFRvIII antibodies and uses thereof
REGENERON PHARMA14 citations92
US8637031B2Jan 28, 2014
Method of treating osteoarthritis with an antibody to NGF
REGENERON PHARMA16 citations92
US7919593B2Apr 5, 2011
Human antibodies to human delta like ligand 4
REGENERON PHARMA25 citations92
US10941210B2Mar 9, 2021
Anti-PCSK9 antibodies
REGENERON PHARMA6 citations84
US9801362B2Oct 31, 2017
Non-human animals expressing pH-sensitive immunoglobulin sequences
REGENERON PHARMA9 citations84
US9648856B2May 16, 2017
Non-human animals expressing pH-sensitive immunoglobulin sequences
REGENERON PHARMA9 citations84
US9308256B2Apr 12, 2016
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
REGENERON PHARMA11 citations84
US10266588B2Apr 23, 2019
Method of treating osteoarthritis with an antibody to NGF
REGENERON PHARMA4 citations83
US9724411B2Aug 8, 2017
Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9
REGENERON PHARMA15 citations83
US12269897B2Apr 8, 2025
Anti-PCSK9 antibodies
REGENERON PHARMA1 citations75
US11370843B2Jun 28, 2022
High affinity antibodies to human IL-6 receptor
REGENERON PHARMA1 citations73
US10738124B2Aug 11, 2020
Anti-EGFRvIII antibodies and uses thereof
REGENERON PHARMA3 citations73
US12543711B2Feb 10, 2026
Non-human animals expressing pH-sensitive immunoglobulin sequences
REGENERON PHARMA0 citations63
US12162943B2Dec 10, 2024
High affinity human antibodies to human IL-4 receptor
REGENERON PHARMA0 citations63
US11224207B2Jan 18, 2022
Non-human animals expressing pH-sensitive immunoglobulin sequences
REGENERON PHARMA0 citations63
US11820815B2Nov 21, 2023
Human antibodies to human delta like ligand 4
REGENERON PHARMA0 citations62
US11608380B2Mar 21, 2023
Anti-EGFRvIII antibodies and uses thereof
REGENERON PHARMA0 citations62
US11518804B2Dec 6, 2022
Method of treating osteoarthritis with an antibody to NGF
REGENERON PHARMA0 citations62
US10047160B2Aug 14, 2018
Anti-EGFRvIII antibodies and uses thereof
REGENERON PHARMA1 citations62
MARTIN JOEL H
5 patentsUS8337839B2Dec 25, 2012
High affinity human antibodies to human IL-4 receptor
MARTIN JOEL H39 citations97
US8075887B2Dec 13, 2011
High affinity human antibodies to human IL-4 receptor
MARTIN JOEL H42 citations96
US8329181B2Dec 11, 2012
Methods for treating B-cell lymphoma by administering an anti-CD20 antibody
MARTIN JOEL H17 citations91
US8097713B2Jan 17, 2012
Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof
MARTIN JOEL H8 citations82
US8414890B2Apr 9, 2013
Human antibodies to human RANKL, encoding nucleic acids and methods of treatment
MARTIN JOEL H12 citations79
MACDONALD LYNN
3 patentsUS8309088B2Nov 13, 2012
Method of treating osteoarthritis with an antibody to NGF
MACDONALD LYNN77 citations97
US8148107B2Apr 3, 2012
High affinity human antibodies to human nerve growth factor
MACDONALD LYNN52 citations97
US8613927B2Dec 24, 2013
High affinity human antibodies to human nerve growth factor
MACDONALD LYNN20 citations92
STEVENS SEAN
3 patentsUS8338135B2Dec 25, 2012
High affinity human antibodies to human IL-4 receptor
STEVENS SEAN33 citations94
US8092802B2Jan 10, 2012
High affinity human antibodies to human IL-4 receptor
STEVENS SEAN33 citations94
US8183014B2May 22, 2012
High affinity antibodies to human IL-6 receptor
STEVENS SEAN11 citations92
RADIN ALLEN
3 patentsUS8568721B2Oct 29, 2013
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
RADIN ALLEN18 citations92
US8192741B2Jun 5, 2012
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
RADIN ALLEN22 citations92
US8080248B2Dec 20, 2011
Method of treating rheumatoid arthritis with an IL-6R antibody
RADIN ALLEN15 citations92
SLEEMAN MARK W
2 patentsShowing the top 50 of 56 patents by PatentIndex Score.